Overview

Plexin B2 Gene Expression and Polymorphisms in Psoriasis : Relation to Narrow Band Ultraviolet B , Acitretin and Combined Therapy

Status:
Active, not recruiting

Trial end date:
2023-08-15

Target enrollment:

Participant gender:

Summary

Patients will be randomly assigned (1:1:1 ) either to ; NB-UVB photo-therapy alone , Acitretin therapy alone or NB-UVB photo-therapy combined with Acitretin therapy randomization will be done by closed envelopes . investigator will be blinded to study drug assignment , while patients and data interpreter will not be masked to study drug assignment.

Phase:

Phase 4

Details

Lead Sponsor:

South Valley University

Treatments:

Acitretin